Survey of patient cohorts receiving DLT after allogeneic SCT
Patient cohort/survey designation . | Author and reference . |
|---|---|
| EBMT registry | |
| EBMT-1995 | Kolb et al13,14 |
| EBMT-2000 | Schmidt et al15 |
| EBMT-2002 | Guglielmi et al16 |
| North American multicenter | |
| USA-1997 | Collins et al17 |
| USA-2000 | Salama et al18 |
| USA-2002 | Levine et al19 |
| European multicenter | |
| Myeloma-2000 | Lokhorst et al20 |
| England multicenter | |
| Lymphoma-2002 | Marks et al21 |
| Munich Bone Marrow Transplant Group | |
| AG-KMT | Kolb et al* |
Patient cohort/survey designation . | Author and reference . |
|---|---|
| EBMT registry | |
| EBMT-1995 | Kolb et al13,14 |
| EBMT-2000 | Schmidt et al15 |
| EBMT-2002 | Guglielmi et al16 |
| North American multicenter | |
| USA-1997 | Collins et al17 |
| USA-2000 | Salama et al18 |
| USA-2002 | Levine et al19 |
| European multicenter | |
| Myeloma-2000 | Lokhorst et al20 |
| England multicenter | |
| Lymphoma-2002 | Marks et al21 |
| Munich Bone Marrow Transplant Group | |
| AG-KMT | Kolb et al* |
Published results of 8 surveys on the use of DLT following allogeneic SCT are reviewed here, as well as results from local Munich transplantation studies.
EBMT indicates European Bone Marrow Transplant.
See “Survey cohorts of patients receiving DLT following allogeneic SCT.”